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Summary
Lipoteichoic acid (LTA) is an important cell wall
polymer in Gram-positive bacteria. The enzyme
responsible for polyglycerolphosphate LTA synthesis
is LtaS, ﬁrst described in Staphylococcus aureus.
Four LtaS orthologues, LtaSBS, YfnI, YqgS and YvgJ,
are present in Bacillus subtilis. Using an in vitro
enzyme assay, we determined that all four proteins
are Mn2+-dependent metal enzymes that use phos-
phatidylglycerol as a substrate. We show that LtaSBS,
YfnI and YqgS can produce polymers, suggesting that
these three proteins are bona-ﬁde LTA synthases
while YvgJ functions as an LTA primase, as indicated
by the accumulation of a GroP-Glc2-DAG glycolipid.
Western blot analysis of LTA produced by ltaSBS, yfnI,
yqgS and yvgJ single, triple and the quadruple
mutant, showed that LTA production was only abol-
ished in the quadruple and the YvgJ-only expressing
mutant. B. subtilis strains expressing YfnI in the
absence of LtaSBS produced LTA of retarded mobility,
presumably caused by an increase in chain length as
suggested by a structural analysis of puriﬁed LTA.
Taken together, the presented results indicate that the
mere presence or absence of LTA cannot account for
cell division and sporulation defects observed in the
absence of individual enzymes and revealed an unex-
pected enzymatic interdependency of LtaS-type pro-
teins in B. subtilis.
Introduction
Teichoic acids are important cell wall components in
Gram-positive bacteria. Usually, two types of teichoic
acids are present, wall teichoic acid (WTA), which is
covalently linked to peptidoglycan and lipoteichoic acid
(LTA), which is tethered to the membrane by a lipid
anchor. WTA polymers are commonly made up of
glycerol- or ribitolphosphate subunits, but tetroses,
hexoses or complex sugar combinations have also been
reported. LTA is usually less diverse and often consists of
a glycerolphosphate chain retained by a glycolipid anchor
in the bacterial membrane (Fischer, 1988; Fischer et al.,
1990; Weidenmaier and Peschel, 2008). Both S. aureus
and B. subtilis synthesize this type of LTA consisting of
an unbranched 1,3-linked polyglycerolphosphate chain
tethered to the bacterial membrane by a diglucosyl-
diacylglycerol (Glc2-DAG) glycolipid (Duckworth et al.,
1975; Fischer, 1988; 1994). The glycerolphosphate sub-
units are esteriﬁed to a varying degree with D-alanine
groups and glycosyl modiﬁcations are also present in
many Bacillus sp. (Fischer and Rosel, 1980; Iwasaki
et al., 1986; Fischer, 1988; 1994; Iwasaki et al., 1989).
While the exact function of teichoic acids is not clear, they
have distinct roles within the cell. The absence of WTA in
B. subtilis leads to cell rounding (D’Elia et al., 2006), while
the absence of LTA leads to the formation of long ﬁla-
ments that spiral along their long axes (Schirner et al.,
2009). S. aureus cells lacking WTA show slight morpho-
logical alterations and are less virulent (Weidenmaier
et al., 2004; 2005), while the absence of LTA causes
severe morphological defects and bacteria are only viable
under certain growth conditions (Gründling and Schnee-
wind, 2007a; Oku et al., 2009). However, a combined
absence of WTA and LTA is lethal for both S. aureus and
B. subtilis (Oku et al., 2009; Schirner et al., 2009), making
enzymes involved in their synthesis promising new drug
targets (Falconer and Brown, 2009).
The enzyme responsible for polyglycerolphosphate LTA
backbone synthesis is LtaS, ﬁrst described in S. aureus
(Gründling and Schneewind, 2007a). LtaS is predicted to
contain ﬁve N-terminal transmembrane helices followed
by a large extracellular enzymatic domain (eLtaS). The
full-length protein is cleaved during growth and the eLtaS
domain is released into the culture supernatant as well as
partially retained within the cell wall fraction (Lu et al.,
2009). Pulse-chase experiments have provided strong
experimental evidence that the glycerolphosphate sub-
units of the LTAbackbone are derived from the membrane
lipid phosphatidylglycerol (PG) (Emdur and Chiu, 1974;
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system, we have recently shown that the puriﬁed S.
aureus eLtaS domain is sufficient to cleave the head
group of ﬂuorescently labelled PG producing diacylglyc-
erol (DAG) and presumably glycerolphosphate, providing
further evidence that this lipid is the physiological sub-
strate for LtaS and LTAsynthesis (Karatsa-Dodgson et al.,
2010).
Interestingly, B. subtilis contains four LtaS orthologues,
namely LtaSBS (YﬂE), YfnI, YqgS and YvgJ with more than
40% identity to S. aureus LtaS. All four proteins have the
same predicted membrane topology and domain structure
as S. aureus LtaS. In addition, all four proteins have an
AXA motif following the transmembrane domain (Fig. S1),
which is reminiscent of and has been predicted to be a
signal peptidase cleavage site (Antelmann et al., 2001).
Furthermore, in proteomic studies processed forms of
LtaSBS and YfnI were detected in the culture supernatant
(Hirose et al., 2000; Tjalsma et al., 2004), showing that at
least some of the B. subtilis proteins are processed and
the enzymatic domains released into the culture superna-
tant similar to what was observed for S. aureus LtaS
(Ziebandt et al., 2001; Gatlin et al., 2006; Lu et al., 2009).
By expressing each of the four B. subtilis orthologues in
an S. aureus ltaS depletion strain it was revealed that
LtaSBS and YfnI encode for LTA synthases, capable of
producing polyglycerolphosphate polymers (Gründling
and Schneewind, 2007a). However, YfnI-produced poly-
mers could not restore the growth defect of an S. aureus
ltaS depleted strain and had an altered mobility on SDS-
PAGE gels, indicative of structural alterations (Gründling
and Schneewind, 2007a). No enzyme activity was
observed for YqgS or YvgJ. Furthermore, a study on the
enzymes in B. subtilis revealed that mutants lacking
LtaSBS grew slower in PAB medium compared with the
wild-type strain and showed a defect in divalent cation
homeostasis, an increase in cell chain length and place-
ment of aberrant septa and enhanced cell bending and
lysis (Schirner et al., 2009). In contrast to S. aureus,aB.
subtilis mutant with disruptions of all four genes could be
readily constructed and was viable. However, this mutant
showed severe morphological defects and bacteria
formed long ﬁlaments that spiralled along their long axes
(Schirner et al., 2009).
To gain further insight into the function of the four B.
subtilis LtaS-type proteins, we investigated their enzy-
matic activities using deﬁned in vitro and in vivo systems.
We show that all four orthologues are able to hydrolyse
ﬂuorescently labelled PG in a Mn2+-dependent manner.
Complementation studies using an S. aureus ltaS deple-
tion strain revealed that YqgS can produce polyglycerol-
phosphate polymers, when expressed at sufficiently high
levels, suggesting that this protein is also a bona-ﬁde LTA
synthase. In contrast, our data indicate that YvgJ func-
tions as an LTA primase, transferring the initial glycerol-
phosphate subunit onto the glycolipid anchor and
therefore producing GroP-Glc2-DAG. Furthermore, in B.
subtilis LtaSBS, YfnI or YqgS are sufficient for polyglycer-
olphosphate polymer production. However, the polymers
produced by a strain expressing YfnI in the absence of
LtaSBS had an altered mobility on SDS-PAGE gels, pre-
sumably caused by an increase in LTA chain length. This
result revealed an unexpected interdependency of YfnI
enzyme activity on the function of LtaSBS in the natural
host B. subtilis. Taken together, this study provides the
ﬁrst experimental evidence for the enzymatic activity of all
four B. subtilis LtaS-type proteins and implications on the
LTA synthesis pathway are discussed.
Results
All four B. subtilis LtaS orthologues are enzymatically
active and hydrolyse ﬂuorescently labelled PG
Enzymatic activities have previously only been detected
for LtaSBS and YfnI, two of the four B. subtilis LtaS ortho-
logues (Gründling and Schneewind, 2007a). Recently, we
have developed an in vitro assay to measure S. aureus
eLtaS enzyme activity (Karatsa-Dodgson et al., 2010).
Using this assay, it was determined that the puriﬁed enzy-
matic domain of S. aureus LtaS, eLtaS, but not the active
site variant eLtaS-T300A hydrolyses the glycerolphos-
phate head group of the ﬂuorescently labelled lipid
NBD-PG resulting in the production of ﬂuorescently
labelled diacylglycerol (NBD-DAG) (Fig. 1A). To deter-
mine if the B. subtilis LtaS orthologues can perform the
same reaction, we cloned, expressed and puriﬁed the
enzymatic domains of all four proteins as N-terminal
His-tagged versions from E. coli extracts (Fig. S1 and
Fig. 1B). Puriﬁed enzymes were mixed with NBD-PG lipid
and incubated for 3 h in the presence of MnCl2. Subse-
quently, lipids were extracted, separated by TLC and
plates scanned using a ﬂuorescence imager to visualize
lipid bands. As a positive control, the commercially avail-
able Bacillus cereus phospholipase PC-PLC (PLC) was
used. This enzyme cleaves PG resulting in the production
of DAG (Shinitzky et al., 1993). When the reactions were
set up using each of the four B. subtilis proteins, two major
ﬂuorescent lipid bands were observed (Fig. 1C). The
faster migrating band had the same mobility as the
hydrolysis product produced by PLC, and presumably
corresponds to NBD-DAG and the slower migrating band
had the mobility of the NBD-PG input lipid. No lipid corre-
sponding to NBD-DAG was detected in reactions set up
without enzyme. In summary, these data demonstrate that
all four recombinant B. subtilis proteins are enzymatically
active and suggest that all proteins hydrolyse the phos-
phodiester bond of NBD-PG resulting in the production of
NBD-DAG.
Activities of Bacillus subtilis LtaS-like enzymes 567
© 2010 Blackwell Publishing Ltd, Molecular Microbiology, 79, 566–583To gain further insight into the relative activity of the
four B. subtilis proteins, a time-course experiment was
performed. Reactions were set up as described above
and samples removed at the indicated time points and
lipid reaction products analysed (Fig. 2A). The amount of
the NBD-DAG reaction product was quantiﬁed (Karatsa-
Dodgson et al., 2010) and % hydrolysis calculated based
on the amount of NBD-DAG produced in the PLC control
reaction, which proceeds to near completion (Fig. 2A).
Three independent experiments were performed and the
ﬁrst three time points, during which the reaction speed
appeared to be linear, were used to determine the
maximal enzyme activity of the four B. subtilis proteins
(Fig. 2B). Enzyme activities ranging from 0.0067 ng (YfnI)
to 0.0007 ng (YvgJ) lipid hydrolysis/(min ¥m M enzyme)
were measured in our in vitro assay set up. These results
indicate that while all four enzymes are active, YfnI,
LtaSBS and YqgS have > 4.6-fold higher activity as com-
pared with YvgJ.
All four B. subtilis LtaS orthologues are Mn2+-dependent
enzymes with substrate speciﬁcity for NBD-PG
Staphylococcus aureus LtaS is a Mn2+-dependent metal
enzyme (Karatsa-Dodgson et al., 2010). In contrast,
structural analysis of the soluble enzymatic domain of the
B. subtilis LtaSBS protein revealed the presence of a Mg2+
ion in the active centre (Schirner et al., 2009). However,
this ion was also present in the crystallization buffer and
as such may not reﬂect the ion relevant for enzyme
activity. To test which metal ion is required for the activity
of the B. subtilis enzymes, in vitro assays were set up in
the presence of different divalent metal ions and the
signal for the reaction product quantiﬁed. As presented in
Fig. 3A and Fig. S2, all four proteins showed the highest
activity in the presence of MnCl2. Addition of MgCl2 and
CaCl2 in place of MnCl2 resulted only in weak enzyme
activity and no activity above background was seen in the
presence of ZnCl2.
Staphylococcus aureus LtaS uses NBD-labelled PG
lipid as substrate but not NBD-PC, NBD-PS or NBD-PE
(Karatsa-Dodgson et al., 2010). Next, we tested the sub-
strate speciﬁcity of the four B. subtilis enzymes and found
that also these enzymes use only NBD-PG as substrate
and not NBD-PC, NBD-PS or NBD-PE (Fig. 2B). Taken
together, these results strengthen the hypothesis that all
members of the LTA synthase enzyme family are Mn2+-
dependent metal enzymes that only use lipids with a
glycerolphosphate head group as substrate.
B. subtilis YqgS is an LTA synthase, capable of
producing polyglycerolphosphate chains
The ﬁnding that YqgS and YvgJ can cleave NBD-PG is
somewhat in contrast to a previously performed comple-
mentation analysis that showed that YqgS and YvgJ could
not promote LTA synthesis in S. aureus (Gründling and
Schneewind, 2007a). One reason why no in vivo activity
for YqgS and YvgJ was observed could be insufficient
expression achieved from the single-copy integration
Fig. 1. In vitro activity of B. subtilis LtaS-type enzymes.
A. Chemical structures of ﬂuorescently labelled NBD-PG and NBD-DAG lipids with known S. aureus LtaS and B. cereus PLC cleavage site
indicated by an arrow.
B. Coomassie stained gel of puriﬁed B. subtilis LtaS-like proteins. Extracellular enzymatic domains of B. subtilis LtaSBS, YfnI, YqgS and YvgJ
were puriﬁed as N-terminal His-tag fusion proteins and 10 mg puriﬁed protein separated on a 10% SDS-PAGE gel and visualized by staining
with Coomassie brilliant blue.
C. TLC analysis of B. subtilis LtaSBS, YfnI, YvgJ and YqgS in vitro reaction products. The NBD-PG lipid substrate was incubated with eLtaSBS,
eYfnI, eYvgJ or eYqgS enzyme. Subsequently, lipids were extracted and separated by TLC and ﬂuorescent lipid bands visualized by scanning
plates with a ﬂuorescence imager. As negative and positive controls, reactions were set up without enzyme or with the B. cereus PLC enzyme
respectively. Note that only 10% of the PLC reaction was run on the TLC plate. Positions of NBD-PG and presumed NBD-DAG reaction
product are indicated on the left and proteins added to each reaction are shown on the top of the panel.
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study (Gründling and Schneewind, 2007a). To test
whether expression of YqgS and YvgJ from a multicopy
plasmid would reveal an in vivo enzyme function for these
proteins, all four B. subtilis genes coding for LtaS-type
proteins and the S. aureus ltaS gene were cloned under
tetracycline-inducible promoter control into the multicopy
plasmid vector pCN34 (Fig. 4A). In addition, the ribosome
binding site (RBS) of yqgS was replaced with the RBS
that precedes the S. aureus ltaS gene, in which a string of
Gs is located eight bases in front of the ATG start codon,
indicative of a good RBS (Vellanoweth and Rabinowitz,
1992). Resulting plasmids and the empty pCN34 vector
control were introduced into S. aureus strain ANG499,
which carries the chromosomal copy of ltaS under IPTG
inducible spac promoter control (Fig. 4A). Functional
complementation of ltaS was examined in the resulting
strains after removal of IPTG by the addition of anhy-
drotetracycline to the growth medium for expression of the
different B. subtilis LtaS orthologues. As described previ-
ously, LtaSBS was able to complement both growth and
LTA production in the S. aureus ltaS depletion strain
whereas YfnI could only promote polyglycerolphosphate
synthesis but not the growth of S. aureus (Fig. 4B and C).
Interestingly, expression of YqgS under these conditions
could also restore bacterial growth, albeit to a lesser
extent than LtaSBS. Furthermore, upon increasing the
exposure time of Western blots, a YqgS-depended signal
for a faster migrating polyglycerolphosphate polymer was
detected, next to other bands, which were also seen in the
negative (no insert) control sample (Fig. 4C). We assume
that these other bands also present in the negative control
sample are LTA-speciﬁc (as they are detected with a
monoclonal antibody) and either due to a slight leakiness
of the inducible spac promoter system or due to small
amounts of LTA remaining on the cells even 4 h after the
shut down of LtaS expression as these bands are absent
from samples isolated from an S. aureus strain with a
complete ltaS deletion (R. Corrigan, unpublished results).
In contrast, even under these conditions, YvgJ expression
did not result in growth of S. aureus or LTA production.
Taken together, these results suggest that YqgS functions
as an LTA synthase, capable of promoting polyglycerol-
phosphate LTA backbone synthesis.
B. subtilis YvgJ functions as an LTA primase
Expression of yvgJ from a strong promoter and a multi-
copy plasmid did not restore growth or LTA production in
the S. aureus ltaS depletion strain, indicating that YvgJ
may not function as an LTA synthase. In a previous study,
it has been shown that the Listeria monocytogenes LtaS-
type protein Lmo0644 encodes for an enzyme that can
transfer one glycerolphosphate subunit onto the glycolipid
anchor and hence we termed this enzyme LTA primase
(Webb et al., 2009). In S. aureus and B. subtilis this reac-
tion would lead to the production of the GroP-Glc2-DAG.
To test if YvgJ could function as an LTA primase and to
investigate if any of the other B. subtilis orthologues are
involved in the production of glycolipid intermediates,
membrane lipids were extracted and analysed from S.
aureus strains expressing B. subtilis LtaSBS, YfnI, YqgS,
YvgJ or S. aureus LtaSSA as a control. Five hundred
micrograms puriﬁed lipids extracted from log-phase cul-
tures were separated on TLC plates and glycolipids visu-
alized by staining with a-naphthol/H2SO4 (Fig. 5). The LTA
Fig. 2. Kinetic measurements for recombinant LtaSBS, YfnI, YqgS
and YvgJ enzymes.
A. Time-course experiment. Enzyme reactions were set up as
described under Experimental procedures, aliquots removed at the
indicated time points and reactions stopped by the addition of
chloroform and methanol. Lipids were separated on TLC plates and
the NBD-DAG reaction product quantiﬁed. For each time point and
enzyme the average value and standard deviation of three values
is plotted. Three independent experiments were performed and a
representative graph is shown.
B. Maximal enzyme activity of B. subtilis LtaSBS, YfnI, YqgS and
YvgJ. The slope of the linear ﬁt through the ﬁrst three data points
of the curve shown in (A) was used to calculate the maximal
enzyme activity for each B. subtilis LtaS orthologue. Three
independent time-course experiments were used to determine an
average value and standard deviation for the maximal enzyme
activity and these values are plotted.
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A. B. subtilis LtaS-type enzymes require Mn
2+ for activity. In vitro enzyme assays were set up with NBD-PG lipid as the substrate in the
presence of 10 mM MgCl2, MnCl2, CaCl2 or ZnCl2 and reactions were initiated by the addition of eLtaSBS. As controls, reactions were set up
without enzyme or without metal ion added. Samples were incubated for 3 h at 37°C, lipids extracted and separated by TLC. Plates were
scanned and signals of the reaction product quantiﬁed. Reactions were set up in triplicate and the average value and standard deviation
plotted. The average ﬂuorescence reading for the reactions set up with MnCl2 was set to 1 and other values were adjusted accordingly.
Similar results were obtained for B. subtilis YfnI, YqgS and YvgJ (see Fig. S2).
B. NBD-PG is the sole lipid substrate for B. subtilis LtaSBS, YfnI, YqgS and YvgJ. Standard enzyme reactions were set up using NBD-PG,
NBD-PS, NBD-PE or NBD-PC as substrate (indicated on the left of the panel) and reactions were initiated by the addition of the different B.
subtilis enzymes. As a negative control, lipid substrates were incubated without enzyme (no enz.) and as a positive control, a PLC reaction
using NBD-PG as substrate was run alongside on each TLC plate in order to determine the mobility of the reaction product. Three
independent experiments were performed and a representative result is shown. Note that only the upper part of the TLC plates is shown with
the area of the reaction product.
Fig. 4. Functional complementation of an S. aureus ltaS-depletion strain with B. subtilis ltaSBS, yfnI, yqgS or yvgJ expressed from a
multicopy plasmid.
A. Schematic representation of complementation strains. S. aureus strains used for complementation analysis contain the chromosomal copy
of ltaS under IPTG inducible expression control and harbour a multicopy plasmid (pCN34) for expression of LtaS orthologues from the
tetracycline inducible promoter.
B. Bacterial growth curves. Washed overnight cultures of S. aureus strains ANG1571 (LtaSSA-expressing), ANG1662 (LtaSBS-expressing),
ANG1573 (YfnI-expressing), ANG1654 (YqgS-expressing) (ANG1658) (YvgJ-expression) and ANG1130 (containing empty vector pCN34; no
insert as negative control) were diluted 1:100 into fresh medium containing 300 ng ml
-1 Atet and growth was monitored by determining OD600
readings at the indicated time points. All cultures were back-diluted 1:100 at the 4 h time point and cultures with strains expressing LtaSSA,
LtaSBS and YqgS were back diluted a second time at the 8 h time point to maintain cultures in the logarithmic growth phase.
C. LTA detection by Western blot. The same S. aureus strains and growth conditions as described above were used for LTA analysis by
Western blot. At the 4 h time point, 1 ml culture aliquots were removed and samples prepared and analysed by Western blot as described in
the Experimental procedures section. For LTA detection, the mouse monoclonal LTA antibody (Clone 55 from Hycult biotechnology) and the
HRP-conjugated anti-mouse IgG antibody (Cell Signaling Technologies, USA) were used at 1:5000 and 1:10 000 dilutions respectively. Sizes
of proteins standards run in parallel are shown on the left of the panel and proteins expressed in each strain are given above each lane. Note
that the LTA Western blot with samples isolated from S. aureus strains expressing YqgS, YvgJ or containing the empty vector (no insert) was
exposed four times longer.
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spectrometry analysis below) could be detected in all
samples. However, the intensity of this glycolipid band
was reduced in samples isolated from YfnI and YvgJ
expressing strains and a concomitant accumulation of the
lower glycolipid band was observed. This lipid species
had the mobility as expected for a GroP-di-saccaride-
DAG lipid (Webb et al., 2009), which would be consistent
with the accumulation of the GroP-Glc2-DAG in-
termediate. To provide further experimental evidence for
this notion, lipids from S. aureus strains expressing LtaSBS
(predominantly producing the top glycolipid band) and
YvgJ (accumulating the bottom glycolipid band) were
separated by TLC and lipids corresponding to a-naphthol/
H2SO4 positive areas extracted and analysed by MALDI
TOF mass spectrometry, which was performed as
described previously (Webb et al., 2009). Sodium adducts
of the glycolipids Glc2-DAG and GroP-Glc2-DAG with C15
and C18 acyl-chains have an absolute calculated mass of
929.62 and 1083.72 respectively (see Table 1). In agree-
ment with these expected masses, m/z signals of 929.59
and 929.66 were observed for lipids isolated from the top
bands of samples obtained from LtaSBS and YvgJ
expressing strains respectively (Fig. 6A and C). In addi-
tion, a strong mass signal of 1083.73 as expected for
GroP-Glc2-DAG was obtained for lipids isolated from the
bottom band of the YvgJ-expressing strain (Fig. 6D). A
corresponding signal was absent from samples prepared
from the LtaSBS expressing strains (Fig. 6B), which does
not show an accumulation of this glycolipid. A complete
list of predicted and observed masses for glycolipids Glc2-
DAG and GroP-Glc2-DAG with varying acyl-chain length
is given in Table 1. Taken together, these data suggest
that YvgJ functions in vivo as an LTA primase capable of
transferring the initial glycerolphosphate subunit onto the
glycolipid anchor producing GroP-Glc2-DAG. Further-
more, despite the fact that YfnI acts as an LTA synthase,
it also appears to be very efficient in synthesizing the
GroP-Glc2-DAG intermediate.
Contribution of LtaSBS, YfnI, YqgS and YvgJ to LTA
synthesis in B. subtilis
A B. subtilis strain deleted of all four ltaS-like genes has
been constructed previously and is viable (Schirner et al.,
Fig. 5. TLC analysis of glycolipids. S. aureus strains ANG1571
(LtaSSA-expressing), ANG1662 (LtaSBS-expressing), ANG1573
(YfnI-expressing), ANG1654 (YqgS-expressing), ANG1658
(YvgJ-expressing) and ANG1130 (containing empty vector pCN34,
no insert as negative control) were grown to mid-log phase and
lipids extracted as described in the Experimental procedures
section. Five hundred mg total membrane lipids were separated by
TLC and glycolipids visualized by staining with a-naphthol/sulphuric
acid. The position of the origin is indicated by a dashed line,
positions of presumed Glc2-DAG (top band) and GroP-Glc2-DAG
(bottom band) lipids are marked with arrows on the right of the
panel and proteins expressed in the different strains are indicated
above each lane.
Table 1. Predicted and observed masses of glycolipids isolated from membranes of S. aureus strains expressing B. subtilis LtaSBS or YvgJ.
Possible fatty acid chain length Chemical formula Predicted mass Observed mass – LtaSBS Observed mass – YvgJ
Top band: Glc2-DAG
C15/C15 C45H84Na1O15 887.57 887.54 887.62
C15/C16 C46H86Na1O15 901.59 901.56 901.62
C15/C17 C47H88Na1O15 915.60 915.58 915.65
C15/C18 C48H90Na1O15 929.62 929.59 929.66
C16/C18 C49H92Na1O15 943.63 943.60 943.67
C17/C18 C50H94Na1O15 957.65 957.61 957.70
Bottom band: GroP-Glc2-DAG
C15/C15 C48H91Na1O20P1 1041.57 Absent 1041.67
C15/C16 C49H93Na1O20P1 1055.59 Absent 1055.70
C15/C17 C50H95Na1O20P1 1069.61 Absent 1069.72
C15/C18 C51H97Na1O20P1 1083.62 Absent 1083.72
C16/C18 C52H99Na1O20P1 1097.64 Absent 1097.73
C17/C18 C53H101Na1O20P1 1111.65 Absent 1111.75
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tion of these genes; a single ltaSBS mutant formed chains,
ltaSBS/yqgS and ltaSBS/yvgJ double mutants had sporula-
tion defects and cells lacking all four genes formed long
chains and spiraled along their long axis (Schirner et al.,
2009). To correlate deletions of ltaS-like genes with the
cellular LTA content, we created single, triple mutants and
the quadruple mutant in the B. subtilis strain 168 by
replacing respective genes with antibiotic resistance
markers. Mutations and strains were conﬁrmed by PCR
analysis and appropriate antibiotic resistance pattern
(yfnI::Cam; yﬂE::Kan; yqgS::Spec; yvgJ::Erm) (Fig. S3).
In addition, when mutant strains were grown in PAB
medium either overnight to stationary phase or until mid-
log phase, we observed similar morphological alterations
as previously described (Fig. S4) (Schirner et al., 2009).
The quadruple mutant formed ﬁlaments that spiraled
along their axes and the ltaSBS mutant formed ﬁlaments
primarily during exponential growth (Fig. S4). Next, cell
extracts were prepared from overnight cultures of wild-
type and mutant B. subtilis strains and the LTA content
analysed by Western blot. Initially, we attempted to use
the mouse monoclonal LTA antibody, which was used for
the above-described S. aureus experiments. However,
when we used this antibody the Western blot signal was
not strong enough to detect LTA from B. subtilis.W e
speculate that this could either be due to lower LTA
amounts or the additional sugar modiﬁcations present on
the LTA backbone in B. subtilis. However, when we used
a humanized monoclonal LTA-speciﬁc antibody, which is
supplied at a higher concentration, an LTA-speciﬁc signal
was obtained for a sample isolated from the wild-type B.
subtilis 168 strain (WT) (Fig. 7). This signal was absent
from samples isolated from a B. subtilis strain lacking all
four ltaS-like genes (4xD) or a strain expressing YvgJ-only
(Fig. 7). Of note, in several samples including the YvgJ-
only and 4xD samples, an additional signal in the 30 kDa
Fig. 6. MALDI-TOF analysis of glycolipids
produced by LtaSBS and YvgJ-expressing S.
aureus strains. A total of 2.5 mg lipids isolated
from LtaSBS or YvgJ-expressing S. aureus
strains were separated by TLC and lipids
corresponding to top and bottom glycolipids
bands extracted and analysed by MALDI-TOF
mass spectrometry. Spectra were recorded in
the reﬂector positive ion mode and are shown
for (A) LtaSBS top band, (B) LtaSBS bottom
band, (C) YvgJ top band and (D) YvgJ bottom
band. Maximal signal intensity is shown in the
top right corner in each panel. Note that the
maximum signal intensity in panel B is lower
than in the other three panels, which ampliﬁes
background signals in the normalized
representation shown. Observed masses
corresponding to calculated masses of
glycolipids are shown in red. Three
independent experiments were performed and
representative spectra are shown.
Fig. 7. LTA production by wild-type and mutant B. subtilis strains.
Samples for LTA analysis by Western blot were prepared from
overnight cultures of wild-type and mutant B. subtilis 168 strains
and from a B. subtilis 168 hybrid strain expressing ribitolphosphate
wall teichoic acid. Samples were separated on a 15% SDS-PAGE
gel, transferred to a PVDF membrane and LTA detected by
Western blot using the humanized monoclonal LTA-speciﬁc
antibody (Biosynexus Incorporated) and the HRP-linked anti-human
antibody (DakoCytomation) at 1:10 000 dilutions. Sizes of protein
standards run in parallel are indicated on the left of the panel and
strains used are indicated above each lane, with abbreviations
given in strain Table 2.
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and could be cross-reactivity towards the WTA polymer,
which in B. subtilis 168 is also predominantly made up of
glycerolphosphate subunits. This signal was less abun-
dant in the B. subtilis 168 hybrid strain L5703 (Karamata
et al., 1987) expressing ribitolphosphate WTA (ribitol-Pi
WTA) in place of glycerolphosphate WTA (Fig. 7). Dele-
tion of yfnI, yqgS or yvgJ alone did not signiﬁcantly affect
LTA production. Interestingly, deletion of ltaSBS resulted in
the production of LTA with an altered mobility on SDS-
PAGE gels, indicative of structural changes (see below).
The production of this altered LTA was attributed to the
function of YfnI, as a B. subtilis strain expressing YfnI-only
showed a similar altered LTA proﬁle (Fig. 7). This also
indicates that LtaSBS affects the activity of YfnI, revealing
an unexpected enzymatic interdependence of the activity
of two LTA-synthases in B. subtilis.
In the case of L. monocytogenes, which produces an
LTA primase and one LTA synthase, a clear difference in
LTA production was seen when the LTA primase was
inactivated (Webb et al., 2009). In B. subtilis no obvious
difference in LTA production was observed upon inactiva-
tion of the LTA primase YvgJ (Fig. 7; compare LTA proﬁle
of DyvgJ strain with wild-type strain). To test more speciﬁ-
cally if the B. subtilis YvgJ enzyme works together with
one of the LTA synthases, we created three B. subtilis
double mutant strain in which YvgJ is expressed with one
of the LTA synthase enzyme LtaSBS, YfnI or YqgS and
compared LTA production in these strains with a strain,
which expresses the synthase alone. No difference in LTA
production was observed for any of the LTA synthases
in the absence of the LTA primase (Fig. 7; compare
lanes LtaSBS-only with express-YvgJ/LtaSBS; YfnI-only
with express-YvgJ/YfnI or YqgS-only with express-YvgJ/
YqgS). This indicates that in contrast to L. monocytogenes
all B. subtilis LTA synthases can efficiently initiate LTA
production even in the absence of a dedicated LTA
primase. However, as shown above and further analysed
below, in B. subtilis LtaSBS affects the function of YfnI.
YfnI synthesizes glycerolphosphate polymers of
increased length
Polymers produced by YfnI in the absence of LtaSBS
migrate with a slower mobility on SDS-PAGE gels, both
when synthesized in the natural host B. subtilis (Fig. 7) or
in the heterologous host S. aureus (Fig. 4C; Gründling
and Schneewind, 2007a). To gain insight into structural
alterations of polymers synthesized by YfnI and to provide
further information on the enzymatic activity of this
protein, we isolated LTA from an S. aureus YfnI-
expressing strain and compared its composition with poly-
mers produced by LtaS. We chose the YfnI-expressing S.
aureus strain for this analysis as we have methods estab-
lished to isolate LTA from this organism and, based on
Western blot analysis, it appeared that S. aureus pro-
duces larger amounts of LTAas compared with B. subtilis.
LTA was isolated from mid-log cultures of S. aureus
strains ANG514 (LtaS-expressing) and ANG515 (YfnI-
expressing) using a 1-butanol extraction method and puri-
ﬁed by hydrophobic interaction chromatography. LTA was
puriﬁed from four independently grown cultures for each
strain and analysed by nuclear magnetic resonance
(NMR) and standard biochemical assays (Fig. 8). Repre-
sentative NMR spectra are shown in Fig. 8Aand B. Based
on the NMR analysis of all four independently isolated LTA
samples, an average glycerolphosphate chain length of
35  6 (LtaS) and 54  6 (YfnI) and average D-Ala modi-
ﬁcation of 82  5% (LtaS) and 74  6% (YfnI) was
calculated. The difference in chain length is considered to
be statistically signiﬁcant (P-value = 0.0048), while the dif-
ference in D-Ala modiﬁcations is not quite statistically
signiﬁcant (P-value = 0.083). In addition, standard bio-
chemical assays were used to determine the phosphate,
glucose and D-Ala content in the puriﬁed LTA samples
(Schnitger et al., 1959; Kunst et al., 1984; Grassl and
Supp, 1995). LTA in a wild-type S. aureus strain is linked
nearly exclusively to the glycolipid anchor Glc2-DAG
(Duckworth et al., 1975) and hence the ratio of the phos-
phate concentration per two glucose molecules can be
used for the chain length determination and the ratio of
D-Ala to phosphate concentration gives a measure for %
D-alanylation.Applying these calculations to LtaS- or YfnI-
produced polymers, revealed an average chain length of
47  9 and 74  14 (Fig. 8C) and % D-alanylation of
62  4 and 68  9 (Fig. 8D) respectively. This biochemi-
cal analysis gives a slightly longer chain length for LtaS
and YfnI-produced LTA as compared with the NMR
analysis. However, both methods indicate that YfnI-
produced polymers are signiﬁcantly longer; 1.5¥ based on
NMR or 1.6¥ based on biochemical assays than LtaS-
produced polymer, but remain linked to a glycolipid
anchor. On the other hand there does not appear to be a
statistically signiﬁcant difference in the amount of D-Ala
substitutions. While this analysis was performed in S.
aureus, we speculate that the observed mobility shift of
YfnI-produced polymers in the natural host B. subtilis is
also due to an increase in chain length, suggesting that in
the absence of LtaS, YfnI-becomes more efficient in LTA
synthesis.
Discussion
Polyglycerolphosphate LTAis found in the cell envelope of
many Gram-positive bacteria. In bacteria that belong to
the phylum Firmicutes, the backbone of this polymer is
synthesized by the LTAsynthase enzyme LtaS (Gründling
and Schneewind, 2007a; Rahman et al., 2009). In con-
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B. subtilis encodes four LtaS-like proteins, namely LtaSBS,
YfnI, YqgS and YvgJ (Gründling and Schneewind, 2007a;
Schirner et al., 2009). Here, we report on the enzymatic
activities of these four B. subtilis LtaS-like proteins (Figs 1
and 2) and show that LtaSBS, YfnI and YqgS are bona-ﬁde
LTAsynthases that can synthesize polyglycerolphosphate
polymers (Figs 4C and 7). In contrast, YvgJ is an LTA
primase, which uses the glycerolphosphate head group of
the membrane lipid PG to form the glycolipid GroP-Glc2-
DAG (Figs 5 and 6), which is assumed to be an LTA
synthesis intermediate.
It is interesting to note that the three recombinant LTA
synthases (LtaSBS, YfnI and YqgS) showed > 4.5-fold
higher activity in the in vitro assay system as compared
with the enzymatic domain of the LTA primase YvgJ
(Fig. 2).Asimilar observation was made with recombinant
versions of the L. monocytogenes LTA synthase and LTA
primase (Karatsa-Dodgson et al., 2010), indicating that
there may be a correlation between the activity of these
enzymes and their ability to produce actual glycerolphos-
phate polymers. Other general features revealed through
the use of the in vitro assay system were that LTA syth-
ases and primases require Mn2+ for in vitro enzyme
activity and only seem to accept lipids with a glycerol-
phosphate head group as substrate but not lipids with
other head groups such as PC, PE or PS (Fig. 3).
Two different models have been proposed for LTA bio-
synthesis that differ in the enzyme activity, which is
required for the actual linkage of the glycerolphosphate
polymer to the glycolipid anchor (recently reviewed in
Rahman et al., 2009). For one model, it was proposed
that an ‘LTA transferase’ moves fully synthesized polyg-
lycerolphosphate polymers from a DAG lipid anchor onto
a glycolipid anchor. This was based on the following
observations: In Streptococcus sanguis a signiﬁcant
amount of polyglycerolphosphate ‘intermediates’ linked to
DAG are present in the membrane (Chiu et al., 1993). In
Fig. 8. NMR and biochemical analysis of puriﬁed LTA.
A and B. NMR analysis. Large cultures of S. aureus strains (A)
ANG514 (LtaSSA-expressing) and (B) ANG515 (YfnI-expressing)
were grown and LTA puriﬁed as described in the Experimental
procedures section. One milligram puriﬁed LTA was suspended and
lyophilized several times in D2O to exchange
1H for
2H deuterons
and
1H NMR spectra were recorded at 600 MHz, 300 K. The
signals derived from citrate, a buffer component used during LTA
puriﬁcation and retained in the samples are marked in grey. The
different signals previously assigned to LTA components (Morath
et al., 2002) are colour coded [blue – D-Ala (4 protons per D-Ala
group), green – GroP (5 protons per GroP group), orange –
CH2/CH3 groups of fatty acids (59 protons per lipid anchor)]. The
integration values are shown above each signal. Chain length was
determined by calculating the ratio of integral values for GroP to
CH2/CH3 groups in fatty acids and % D-Ala substitution by
calculating the ratio of integral values for D-Ala to GroP x 100 and
taking into account the number of protons for each signal. NMR
analysis was performed on four independently isolated LTA
samples for each strain and a representative result is shown.
C and D. Biochemical analysis of LTA. LTA extracted from strains
ANG514 (LtaSSA) and ANG515 (YfnIBS) was subjected to a
biochemical analysis. Phosphate, glucose and D-Ala contents were
determined as described in the Experimental procedures section.
GroP, D-Ala and glucose solutions of known concentrations were
used as standards. The chain length in GroP subunits (C) was
determined by calculation of the ratio of phosphate/
1/2 glucose
concentration and the % D-Ala substitution (D) by calculating the
ratio of D-Ala/phosphate concentration ¥ 100. Biochemical analysis
was performed on four independently isolated LTA samples for
each strain and the mean and standard deviation is shown. The
difference in chain length is statistically signiﬁcant and indicated
with an asterisk (*) (two-tailed P-value of 0.017; unpaired T-test)
while the difference in D-Ala modiﬁcation is not (two-tailed P-value
of 0.355, unpaired T-test).
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necessary for their synthesis (Button and Hemmings,
1976; Kiriukhin et al., 2001; Fedtke et al., 2007) or natural
lack of these genes as found in some Bacillus sp. (Iwasaki
et al., 1986), polyglycerolphosphate polymers are directly
linked to DAG. Hence, it was proposed that the DAG-
linked polymers are natural LTA synthesis intermediates,
which are subsequently moved by an LTA transferase
enzyme onto the glycolipid anchor. In the second model
an LTA primase adds the ﬁrst glycerolphosphate subunit
to the glycolipid anchor to form the GroP-glycolipid
intermediate. Subsequently, an LTA synthase adds
additional glycerolphosphate subunits onto this GroP-
glycolipid intermediate to produce the LTA backbone
chain. The discovery of an LTA primase in L. monocyto-
genes (Webb et al., 2009) and, as described in this study,
now also in B. subtilis favours the second model.
However, we postulate that the action of an LTA primase
and the production of the GroP-glycolipid intermediate will
only in some cases and to some extent aid in the LTA
synthesis process. We propose, in addition to this two-
enzyme system, a slightly altered version of the latter
model in which only a single enzyme is needed for LTA
synthesis. In this model, a single enzyme can directly start
and extend the glycerolphosphate chain on the glycolipid
anchor, regardless of how many LtaS-type enzymes are
encoded in the genome. We have shown that enzymes
with LTA synthase and LTA primase activity belong
to the same family of proteins (LtaS-type enzymes).
Members of this protein family show a high degree of
identity on the amino acid level and have the same pre-
dicted membrane topology and domain structure (Fig. 9).
Therefore, we are conﬁdent that in the genome of S.
aureus and several other Gram-positive bacteria, only
one LtaS-type enzyme is encoded and hence we suggest
that this enzyme functions as both an LTA synthase and
an LTA primase. In addition, the B. subtilis YfnI enzyme
produces both polyglycerolphosphate polymers and the
GroP-Glc2-DAG intermediate (Figs 4C, 5 and 7), provid-
ing further evidence that the same LtaS-type enzyme can
be an LTA synthase and an LTA primase. Furthermore,
deletion of the dedicated LTA primase YvgJ in B. subtilis
does not lead to an obvious difference in LTA production,
suggesting that all B. subtilis LTA synthases are able to
efficiently initiate LTAsynthesis independent of the activity
of a dedicated LTA primase (Fig. 7). Therefore, we
suggest that while LtaS-type enzymes are very selective
for their lipid substrate (they can only cleave the head
group of PG), at least some of them have a relaxed
speciﬁcity towards the acceptor lipid that can be used for
the subsequent glycerolphosphate transfer reaction. For
example, S. aureus LtaS can use DAG, Glc2-DAG, GroP-
Glc2-DAG and the polyglycerolphosphate chain. However,
the efficiencies with which these different acceptor mol-
ecules can be used will vary between each individual
enzyme and dictate how efficiently LTA can be synthe-
sized in the absence of glycolipids or a dedicated primase
and might also inﬂuence the ﬁnal chain length of LTA
molecules.
Using BLAST homology searches, we investigated
whether it is possible to distinguish between LTA syn-
thases and dedicated LTA primases (such as the B. sub-
tilis YvgJ and L. monocytogenes Lmo0644 proteins).
However, we did not ﬁnd any motifs that would allow us to
predict which LtaS-type enzyme is an LTA synthase and
which protein would only function as an LTA primase.
Additional structural information on LTA synthases and
LTA primases especially in their full-length membrane
form, combined with additional in vitro assay studies
investigating speciﬁcally the glycerolphosphate transfer
Fig. 9. Schematic representation of in vivo activities of the four B. subtilis LtaS-type enzymes.
A. B. subtilis LtaSBS is the ‘house-keeping’ LTA synthase, which is active during vegetative growth.
B. B. subtilis YfnI is assumed to be the ‘stress’ LTA synthase as yfnI transcription is controlled by sigma M, which is important during cell
envelope stress. YfnI is capable of promoting polyglycerolphosphate synthesis as well as producing the GroP-Glc2-DAG glycolipid
intermediate. Here we show that YfnI activity is inﬂuenced by the presence/absence of LtaSBS. Processed forms of both, LtaSBS and YfnI have
been detected in the culture supernatant and processing of YfnI is reduced in the combined absence of the two signal peptidases SipT and
SipV (Antelmann et al., 2001).
C. B. subtilis YqgS has LTA synthase activity and is important during the sporulation process.
D. YvgJ functions as an LTA primase synthesizing the glycolipid intermediate GroP-Glc2-DAG. Although YqgS and YvgJ contain an AXA motif it
is not clear if these enzymes are processed in B. subtilis. LTA synthases are depicted in blue and LTA primases in red. Numbers refer to
amino acid positions and arrows indicate cleavage or potential cleavage sites.
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would help us shed light on this question.
Bacillus subtilis strains lacking individual ltaS-like
genes or combinations of the four genes display several
phenotypes. For instance, a single ltaSBS mutant formed
chains, an ltaSBS/yqgS double mutant has a sporulation
defect and cells lacking all four genes form long chains
and spiraled along their long axis (Fig. S4) (Schirner
et al., 2009). Here, we show that the mere presence or
absence of polyglycerolphosphate polymers cannot
account for the observed ﬁlamentation and sporulation
defect, as a strain deleted for ltaSBS or ltaSBS/yqgS is still
capable of producing a glycerolphosphate polymer
(Fig. 7). Previously, both LtaSBS and YqgS expressed as
GFP-fusion proteins from an inducible promoter system
were found to localize preferentially to the division site or
sporulation septum (Schirner et al., 2009). Taken together
with our ﬁnding on the LTA production in the different
mutant strains (Fig. 7), this would indicate that in the
absence of LtaSBS, YqgS produces functional polyglycer-
olphosphate polymers at the sporulation septum and that
polymers synthesized by YfnI are either not produced at
the sporulation septum or are not functional due to their
structural alterations (see below).
We show that a B. subtilis ltaSBS deletion strain as well
as a strain expressing YfnI as a sole LTA synthase pro-
duces polymers that migrated slower on SDS-PAGE gels
compared with wild-type LTA (Fig. 7). This was also
observed when yfnI was expressed in an S. aureus ltaS
depletion strain (Fig. 4C) (Gründling and Schneewind,
2007a), indicating that the altered mobility of LTA pro-
duced by YfnI in S. aureus is not an artefact, but reﬂects
the natural property of this enzyme. NMR and biochemical
analysis of LTA puriﬁed from S. aureus strains expressing
LtaS or YfnI revealed a 1.5- to 1.6-fold increase in chain
length for YfnI-produced polymers (Fig. 8), and this pre-
sumably results in the slower mobility on SDS-PAGE gels.
The presence of longer polymers in the absence of LtaSBS
is somewhat puzzling and suggests that the activity of YfnI
changes in the presence of LtaSBS, or that YfnI and LtaSBS
compete for the PG lipid substrate and that YfnI can only
synthesize long polymers in the absence of LtaSBS due to
an increased availability of PG. Alternatively, LtaSBS could
trim YfnI-produced polymers and hence these long poly-
mers are only seen in the absence of LtaSBS.
Currently, it is not known if there are any natural condi-
tions under which YfnI would be expressed in the absence
of LtaSBS and hence lead to the production of elongated
LTAmolecules.Aprevious study using transcriptional lacZ
reporter gene fusions showed low expression of yqgS,
yvgJ and yfnI compared with ltaSBS during growth of B.
subtilis in PAB medium (Schirner et al., 2009), which,
together with all other evidence, suggests that LtaSBS is
the ‘house-keeping’ LTA synthase. In proteomic studies
processed forms of both LtaSBS and YfnI were detected in
the culture supernatant of late-exponential phase B. sub-
tilis cultures when grown in minimal medium (Hirose et al.,
2000), showing that both of these LTA synthases are
produced under these conditions. In addition, YfnI was
found in culture supernatants of exponential as well as
stationary phase B. subtilis cultures when grown in
L-broth (Antelmann et al., 2001). But most notably, it has
also been described that yfnI expression is controlled by
the alternative sigma factor sigma M (Jervis et al., 2007;
Eiamphungporn and Helmann, 2008) and hence its
expression is activated under speciﬁc stress conditions
such as high salt, low pH, heat and certain antibiotics
(Thackray and Moir, 2003; Jervis et al., 2007; Eiamphun-
gporn and Helmann, 2008). It could be that under these
conditions LTA of slightly different structure is synthesized
to better cope with speciﬁc stress conditions. However, it
has been reported that a yfnI deletion strain is not more
sensitive to salt stress as compared with a wild-type strain
(Schirner et al., 2009), but additional studies are needed
to determine if YfnI could indeed be a ‘stress LTA-
synthase’. During sporulation YqgS is essential in the
absence of the ‘house-keeping’ LTA synthase LtaSBS
(Schirner et al., 2009), and therefore could be termed
sporulation LTA synthase (Fig. 9). The function of the LTA
primase YvgJ during growth of B. subtilis is least clear and
only the somewhat reduced sporulation efficiency in the
absence of both LtaSBS and YvgJ would indicate that the
GroP-Glc2-DAG intermediate produced by YvgJ plays a
role during the sporulation process (Fig. 9). It is interest-
ing to note that accumulation of the GroP-Glc2-DAG gly-
colipid intermediate upon YvgJ expression leads to a
concomitant decrease in the amount of the glycolipid Glc2-
DAG (Fig. 5), suggesting that the total glycolipid pool is
held constant in the cell and that GroP-Glc2-DAG is part of
this glycolipid pool. This could indicate that GroP-Glc2-
DAG might still be able to traverse the membrane and
reach the cytoplasm of the cell where it could cause a
feedback inhibition on cytoplasmic glycolipid synthesizing
enzymes (UgtP in B. subtilis or YpfP in S. aureus).
Most Bacillus species produce LTA of the polyglycerol-
phosphate type (Iwasaki et al., 1986; 1989). However,
based on literature searches and sequence analysis, at
least Bacillus circulans, Bacillus pseudoﬁrmus OF4 and
Bacillus halodurans C125 lack the LTA polymer or LtaS-
type enzymes. B. circulans falls into an ungrouped class of
Bacillaceae species (Xu and Cote, 2003) and the latter two
strains are alkaliphilic bacteria (Iwasaki et al., 1989;
Takami et al., 2000). It has been shown that the alkaliphilic
strain B. halodurans contains, in place of teichoic acids,
teichuronopeptides as major cell wall components, which
are co-polymers of polyglutamic acid and polyglucoronic
acid (Takami et al., 2000). Several sequenced Bacillus
species,namelyBacillusselenitireducensMLS10,Bacillus
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ently encode only a single LtaS homologue, which should
be sufficient for polyglycerolphosphate LTA synthesis.
However, the majority of Bacillus species encode multiple
LtaS-type proteins. At the present it is still not completely
understood why bacteria such as B. subtilis produce mul-
tipleproteins.Howeverasshownhere,allfourproteinsare
involved in the LTA synthesis process, they have distinct
enzymatic activities within the cell and there is a functional
interdependency of their enzymatic activities. Presumably
the co-ordinate expression and activity of these proteins
allow B. subtilis to ﬁne-tune LTA synthesis under different
growth and stress conditions and during the sporulation
process. Based on this and previous studies, it is now
becomingmoreandmoreapparentthatLTAfunctionistied
to its exact structure, spatial distribution and/or localized
synthesis (Schirner et al., 2009). To determine the exact
function of LTA for bacterial growth and its alterations
during different growth conditions warrants further
analysis.
Experimental procedures
Bacterial strains and growth conditions
All strains used in this study are listed in Table 2. Escherichia
coli and S. aureus strains were grown at 37°C in Luria–
Bertani (LB) and tryptic soya broth (TSB) respectively. B.
subtilis strains were grown in LB, or Difco Antibiotic Medium
3 (PAB medium) at 30°C or 37°C as indicated. When appro-
priate, the medium was supplemented with antibiotics as
indicated in Table 2.
Strain and plasmid construction
Primers used in this study are listed in Table 3. Plasmids
pProEX-eYﬂE, pProEX-eYfnI, pProEX-eYvgJ and pProEX-
eYqgS were constructed for the expression and puriﬁcation of
N-terminally His-tagged versions of the extracellular enzy-
matic domains of the four B. subtilis LtaS orthologues.
Respective gene fragments (Fig. S1) were ampliﬁed from B.
subtilis 168 chromosomal DNA using primer pairs 5-BamHI-
YﬂE-Cterm/3-XbaI-YﬂE with stop, 5-BamHI-YfnI-Cterm/3-
XbaI-YfnI with stop, 5-BamHI-YvgJ-Cterm/3-XbaI-YvgJ with
stop, 5-BamHI-YqgS-Cterm/3-XbaI-YqgS with stop and
cloned BamHI/XbaI into plasmid pProEX-HTb (Invitrogen)
that has been cut with the same enzymes. The resulting
plasmids were initially transformed into E. coli strain DH5a
resulting in strains ANG1444 (pProEX-eYﬂE), ANG1445
(pProEX-eYfnI), ANG1446 (pProEX-eYvgJ) and ANG1447
(pProEX-eYqgS). For protein expression and puriﬁcation
plasmids were introduced into the E. coli Rosetta strain yield-
ing strains ANG1474 (pProEX-eYﬂE), ANG1475 (pProEX-
eYfnI), ANG1476 (pProEX-eYvgJ) and ANG1477 (pProEX-
eYqgS). Plasmids pCN34itet-ltaS, pCN34itet-yfnI, pCN34itet-
yﬂE, pCN34itet-yvgJ and pCN34itet-yqgS were constructed
to study the functions of the corresponding proteins in an S.
aureus ltaS depletion strain. For the construction of plasmids
pCN34itet-ltaS and pCN34itet-yfnI, respective genes and the
pitet promoter region were ampliﬁed from plasmids pitet-ltaS
and pitet-yfnI using primer pairs 5-KpnI-tet/3-SalI-pCL55 and
5-KpnI-tet/3-P-pCL55 respectively. The resulting PCR prod-
ucts were cut with KpnI/SalI (ltaS) or KpnI (yfnI) and cloned
into pCN34 that has been cut with KpnI/SalI (ltaS cloning) or
KpnI/SmaI (yfnI cloning). For pCN34itet-yﬂE, pCN34itet-yvgJ
and pCN34itet-yqgS plasmid construction, the respective
genes and the pitet promoter were ampliﬁed from plasmids
pitet-yﬂE,p itet-yvgJ and pitet-RBltaS-yqgS using primer pair
5-KpnI-tet/3-PstI-pCL55. The resulting PCR products were
cut with KpnI and PstI and ligated with pCN34, which has
been cut with the same enzymes. Plasmids were subse-
quently transformed into E. coli XL1 Blue resulting in strains
ANG1512 (pCN34itet-ltaS), ANG1514 (pCN34itet-yfnI),
ANG1660 (pCN34itet-yﬂE), ANG1656 (pCN34itet-yvgJ) and
ANG1652 (pCN34itet-yqgS). These plasmids and the empty
pCN34 control vector were then electroporated into the ltaS-
inducible S. aureus strainANG499, yielding strainsANG1130
(pCN34), ANG1571 (pCN34itet-ltaS), ANG1573 (pCN34itet-
yfnI),ANG1662 (pCN34itet-yﬂE),ANG1658 (pCN34itet-yvgJ)
and ANG1654 (pCN34itet-yqgS). Plasmids pCL55-ltaS
and pCL55-yqgS, which were used as DNA templates in
PCR reactions for the construction of pCN34itet-ltaS and
pCN34itet-yqgS were constructed as follows: ltaS and yqgS
genes were ampliﬁed from S. aureus RN4220 and B. subtilis
168 chromosomal DNA, respectively, using primer pair
5′-BamHI +P SAV0719/3-KpnI-SAV719 and 5-BamHI-YqgS-
with P/3-KpnI-YqgS. Resulting PCR products were cut with
BamHI and KpnI and ligated with plasmid pCL55, which had
been cut with the same enzymes. Plasmids were subse-
quently transformed into E. coli strain XL1 Blue resulting in
strains ANG503 (pCL55-ltaS) and ANG506 (pCL55-yqgS).
Plasmid pitet-RBltaS-yqgS, which was used to amplify yqgS
for the construction of pCN34itet-yqgS, contains the yqgS
gene proceded by the S. aureus ltaS RBS under tetracycline
inducible promoter control. This plasmid was obtained by
amplifying the ltaS promoter and RBS from plasmid pCL55-
ltaS using primer pair 5′-BamHI +P SAV0719/R-YqgS-PLtaS
and the yqgS coding sequence from plasmid pCL55-yqgS
using primer pair N-F-PltaS-YqgS/3-BglII-YqgS. The resulting
PCR products were fused by SOE (Splice Overlap Extension)
PCR (Horton et al., 1989) using primer pair 5′AvrII-PltaS-
yqgS/3-BglII-YqgS. The ﬁnal PCR product was cut with AvrII/
BglII and yqgS with the ltaS RBS was placed under
tetracycline inducible promoter control by ligating the cut
PCR product with the AvrII/BglII cut plasmid pitet. The result-
ing plasmid pitet-RBltaS-yqgS was transformed into E. coli
strain XL1 Blue, yielding strain ANG1615. Sequences of all
inserts were veriﬁed by ﬂuorescence automated sequencing
at the MRC Clinical Science Center Sequencing Facility at
Imperial College London.
Bacillus subtilis single, double, triple and quadruple yfnI,
yﬂE (ltaSBS), yqgS and yvgJ mutants were constructed by
replacing each gene with an antibiotic resistance marker
(yfnI::Cam, yﬂE::Kan, yqgS::Spec, yvgJ::Erm). The initial
single mutants were obtained by transforming PCR products
composed of the antibiotic resistance cassette ﬂanked by
~900 bp upstream and downstream DNA fragments of the
respective gene. Subsequent mutants were produced using
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Strain Relevant features Reference
Escherichia coli strains
XL1 Blue Cloning strain, TetR – ANG127 Stratagene
DH5a Cloning strain – ANG397 Hanahan (1983)
Rosetta Strain used for protein expression – ANG574 Novagen
ANG201 pCN34 in E. coli; source for Kan (aphA-3) marker; KanR and AmpR Charpentier et al. (2004)
ANG203 pCN49 in E. coli; source for Erm (ermC) marker; AmpR Charpentier et al. (2004)
ANG204 pCN55 in E. coli; source for Spec (add9) marker; AmpR Charpentier et al. (2004)
ANG243 pCL55 in XL1 Blue; S. aureus single-site integration vector; AmpR Lee et al. (1991)
ANG284 pitet in XL1 Blue; E. coli / S. aureus shuttle vector with tetracycline inducible promoter; AmpR Gründling and Schneewind (2007b)
ANG503 pCL55-ltaS in XL1 Blue; AmpR This study
ANG506 pCL55-yqgS in XL1 Blue; AmpR This study
ANG508 pitet-ltaS in XL1 Blue; ltaS under tetracycline inducible promoter; AmpR Gründling and Schneewind (2007a)
ANG509 pitet-yfnI in XL1 Blue; yfnI under tetracycline inducible promoter; AmpR Gründling and Schneewind (2007a)
ANG510 pitet-yﬂE in XL1 Blue; yﬂE under tetracycline inducible promoter; AmpR Gründling and Schneewind (2007a)
ANG512 pitet-yvgJ in XL1 Blue; yvgJ under tetracycline inducible promoter; AmpR Gründling and Schneewind (2007a)
ANG1444 pProEX-eYﬂE in DH5a; plasmid for overexpression of eYﬂE (eLtaSBS) domain; N-terminal
His-tag; AmpR
This study
ANG1445 pProEX-eYfnI in DH5a; plasmid for overexpression of eYﬂnI domain; N-terminal His-tag; AmpR This study
ANG1446 pProEX-eYvgJ in DH5a; plasmid for overexpression of eYvgJ domain; N-terminal His-tag;
AmpR
This study
ANG1447 pProEX-eYqgS in DH5a; plasmid for overexpression of eYqgS domain; N-terminal His-tag;
AmpR
This study
ANG1474 pProEX-eYﬂE in Rosetta strain; strain use for overexpression of eYﬂE (eLtaSBS) protein with
N-terminal His tag; AmpR
This study
ANG1475 pProEX-eYfnI in Rosetta strain; strain use for overexpression of eYfnI protein with N-terminal
His tag; AmpR
This study
ANG1476 pProEX-eYvgJ in Rosetta strain; strain use for overexpression of eYvgJ protein with N-terminal
His tag; AmpR
This study
ANG1477 pProEX-eYqgS in Rosetta strain; strain use for overexpression of eYqgS protein with N-terminal
His tag; AmpR
This study
ANG1512 pCN34itet-ltaS in XL1 Blue; ltaS under tetracycline inducible promoter; KanR, AmpR This study
ANG1514 pCN34itet-yfnI in XL1 Blue; yfnI under tetracycline inducible promoter; KanR, AmpR This study
ANG1615 pitet-RBltaS-yqgS in XL1 Blue; yqgS with ltaS ribosomal binding site under tetracycline
inducible promoter; AmpR
This study
ANG1652 pCN34itet-yqgS in XL1 Blue; yqgS under tetracycline inducible promoter; KanR, AmpR This study
ANG1656 pCN34itet-yvgJ in XL1 Blue; yvgJ under tetracycline inducible promoter; KanR, AmpR This study
ANG1660 pCN34itet-yﬂE in XL1 Blue; yﬂE (ltaSBS) under tetracycline inducible promoter; KanR, AmpR This study
ANG1676 pCN38 in E. coli; source for Gram-positive Cam (cat194) marker; AmpR Charpentier et al. (2004)
Staphylococcus aureus strains
RN4220 Transformable laboratory strain Kreiswirth et al. (1983)
ANG499 RN4220 with IPTG-inducible ltaS expression; ErmR, IPTG Gründling and Schneewind (2007a)
ANG514 pitet-ltaS integrated in strain ANG499; ErmR, CamR, IPTG Gründling and Schneewind (2007a)
ANG1130 ANG499 with pCN34; ErmR, KanR, IPTG This study
ANG1571 ANG499 with pCN34itet-ltaS; ErmR, KanR, IPTG This study
ANG1573 ANG499 with pCN34itet-yfnI; ErmR, KanR, IPTG This study
ANG1654 ANG499 with pCN34itet-yqgS; ErmR, KanR, IPTG This study
ANG1658 ANG499 with pCN34itet-yvgJ; ErmR, KanR, IPTG This study
ANG1662 ANG499 with pCN34itet-yﬂE; ErmR, KanR, IPTG This study
Bacillus subtilis strains
B. subtilis Bacillus subtilis 168 – Transformable lab strain, trpC2 – ANG1691 Burkholder and Giles (1947)
ANG1692 Bacillus subtilis 168 yfnI::Cam (DyfnI) This study
ANG1693 Bacillus subtilis 168 yﬂE::Kan (DltaSBS) This study
ANG1694 Bacillus subtilis 168 yqgS::Spec (DyqgS) This study
ANG1695 Bacillus subtilis 168 yvgJ::Erm (DyvgJ) This study
ANG1696 Bacillus subtilis 168 yﬂE::Kan, yqgS::Spec, yvgJ::Erm (yfnI only) This study
ANG1697 Bacillus subtilis 168 yfnI::Cam, yqgS::Spec, yvgJ::Erm (ltaSBS only) This study
ANG1698 Bacillus subtilis 168 yfnI::Cam, yﬂE::Kan, yvgJ::Erm (yqgS only) This study
ANG1699 Bacillus subtilis 168 yfnI::Cam, yﬂE::Kan, yqgS::Spec (yvgJ only) This study
ANG1701 Bacillus subtilis 168 yfnI::Cam, yﬂE::Kan, yqgS::Spec, yvgJ::Erm (4xD) This study
ANG1702 Bacillus subtilis 168 yﬂE::Kan, yfnI::Cam (express-yvgJ/yqgS) This study
ANG1703 Bacillus subtilis 168 yﬂE::Kan, yqgS::Spec (express-yvgJ/yfnI) This study
ANG1704 Bacillus subtilis 168 yfnI::Cam, yqgS::Spec (express-yvgJ/yﬂE) This study
L5703 Bacillus subtilis with ribitol-Pi wall teichoic acid (ribitol-Pi WTA) Karamata et al. (1987)
Antibiotics were used at the following concentrations: for E. coli cultures: ampicillin (AmpR) 100 mgm l -1; kanamycin (KanR) 30 mgm l -1; tetracycline (TetR)
10 mgm l -1;f o rS. aureus cultures: erythromycin (ErmR) 10 mgm l -1; chloramphenicol (CamR) 7.5 to 10 mgm l -1 and IPTG at 1 mM; for B. subtilis cultures:
erythromycin 5 mgm l -1; chloramphenicol 10 mgm l -1; kanamycin 10 mgm l -1; spectinomycin (Spec) 100 or 200 mgm l -1.
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mation reactions. Initial PCR products were obtained as
follows: primer pairs 5-1kb-YfnI/3-ApaI-YfnI, 5-1kb-YﬂE/3-
ApaI-YﬂE, 5-1kb-YqgS/3-ApaI-YqgS and 5-1kb-YvgJ/3-ApaI-
YvgJ were used to amplify ~900 bp fragments upstream of
each gene and the resulting PCR products were cut with
ApaI. Primer pairs 5-XhoI-YfnI/ 3-1kb-YfnI, 5-XhoI-YﬂE/
3-1kb-YﬂE, 5-XhoI-YqgS/3-1kb-YqgS and 5-XhoI-YvgJ/3-
1kb-YvgJ were used to amplify ~900 bp fragments down-
stream of the respective genes and the resulting PCR
products were cut with the restriction enzyme XhoI. Antibiotic
resistance cassettes were excised with ApaI and XhoI from
plasmids pCN38 (Cam), pCN34 (Kan), pCN54 (Spec) and
pCN49 (Erm) and appropriate upstream DNA fragments –
resistance marker – downstream DNA fragments were
ligated overnight. An aliquot of these ligation reactions was
used for a ﬁnal PCR ampliﬁcation step together with the
outside primers 5-1kb-YfnI/3-1kb-YfnI, 5-1kb-YﬂE/3-1kb-
YﬂE, 5-1kb-YqgS/3-1kb-YqgS and 5-1kb-YvgJ/3-1kb-YvgJ. B.
subtilis transformations were performed using the two-step
transformation procedure as described previously (Cutting
& Vander Horn, 1988) and transformants were selected
on LB agar plates containing the appropriate antibiotic.
All mutations were veriﬁed by PCR using primer pairs
5-AvrII-YfnI-33bp/3-BglII-YfnI, 5-AvrII-YﬂE-32bp/3-BglII-YﬂE,
5-AvrII-YqgS-34bp/3-BglII-YqgS and 5-AvrII-YvgJ-33bp/3-
BglII-YvgJ (2) and chromosomal DNA, which was prepared
using the FastDNA kit (MP-Biomedicals). Replacement of
yfnI, yﬂE, yqgS and yvgJ genes with the resistance marker
resulted in a PCR product of reduced size.
Table 3. Primers used in this study.
Number Name Sequence
ANG086 5′-BamHI +P SAV0719 CGGGATCCGGAATAGAATATAGAATGCAATTAGAAATG
ANG159 5-KpnI-tet GGGGTACCTTGGTTACCGTGAAGTTACCATCACGG
ANG317 3-KpnI-SAV719 GGGGTACCCCGAGTTCGTGTTTAAATATTATTTTTTAG
ANG322 5-AvrII-YfnI-33bp CCGCCTAGGGAACTTAAAGTGTTTAAGAAAGTAGAGGTTGCC
ANG323 3-BglII-YfnI GAAGATCTGCAATGCGCCCGCTCAAGGCTCTTTTTCATCTTA
ANG326 5-AvrII-YﬂE-32bp CCGCCTAGGGCTCGAACTGGATCGGAAAAAAGGAGTGTAACA
ANG327 3-BglII-YﬂE GAAGATCTAAAGCGGAGAGGGCAACCTCTCCGCTTTTTCTTA
ANG328 5-BamHI-YqgS- with P CGGGATCCGTCGAGAAAACATTCCGCAAATGCGCGTTTCCG
ANG329 3-KpnI-YqgS GGGGTACCCCGCTCACTTCGATGCGGGAGACATTGTGATTA
ANG330 5-AvrII-YqgS-34bp CCGCCTAGGCTGATTTTTTTGAGCGTGCTGCATAGGAGGTTG
ANG331 3-BglII-YqgS GAAGATCTCCGCTCACTTCGATGCGGGAGACATTGTGATTA
ANG334 5-AvrII-YvgJ-33bp CCGCCTAGGCAGATGATCAAGAAAACGTGAGGAGTCATATTG
ANG337 3-BeglII-YvgJ (2) GAAGATCTGGACTACAAGGCGAATCTGTCTCATTTAAA
ANG579 5-BamHI-YﬂE-Cterm CGGGATCCGATTCCAGCGACGTAACGGAAGTAG
ANG580 3-XbaI-YﬂE with stop CGTCTAGAGGGCAACCTCTCCGCTTTTTCTTATTTATC
ANG581 5-BamHI-YfnI-Cterm CGGGATCCAGCAGCGATGATTTAACAAGTGTCGAG
ANG582 3-XbaI-YfnI with stop CGTCTAGAGCGCCCGCTCAAGGCTCTTTTTCATCTTA
ANG583 5-BamHI-YvgJ-Cterm CGGGATCCGATGAAGACAGTATAACTGCCATTAAAAAC
ANG584 3-XbaI-YvgJ with stop CGTCTAGACCCTCTTGATAGAGGGATTTTTTCA
ANG585 5-BamHI-YqgS-Cterm CGGGATCCGACAGCAACAGCCTGACGGAGATTG
ANG586 3-XbaI-YqgS with stop CGTCTAGACTTCGATGCGGGAGACATTGTGATTA
ANG775 R-YqgS-PLtas CGTTTTTCGCATGATTCTTTCCCCCGTTATTTAGATAATAAATC
ANG796 N-F-PltaS-YqgS GGGGAAAGAATCATGCGAAAAACGTTTTTTTCGAAGATTTC
ANG800 3-SalI-pCL55 ACGCGTCGACCACGTTTCCATTTATCTGTATACGGATC
ANG821 3-P-pCL55 P-CACGTTTCCATTTATCTGTATACGGATC
ANG826 5′AvrII-PltaS-yqgS CCGCCTAGGCTAAATAACGGGGGAAAGAATCATG
ANG877 3-PstI-pCL55 CGGCTGCAGCACGTTTCCATTTATCTGTATACGGATC
ANG1070 5-1kb-YfnI CTTCCGAAAGACCCTGAAACGC
ANG1071 3-ApaI-YfnI CCGGGGCCCGGCAACCTCTACTTTCTTAAACAC
ANG1072 5-XhoI-YfnI CCGCTCGAGCTATCATTACGGCAAGGAGAAAGAAATC
ANG1073 3-1kb-YfnI CCCATCTTTGGCAAGGTTCTTCAGC
ANG1076 5-1kb-YﬂE GATTGTCTGTTTGAAAATGTATAAAGG
ANG1077 3-ApaI-YﬂE CCGGGGCCCTGTTACACTCCTTTTTTCCGATCCAG
ANG1078 5-XhoI-YﬂE CCGCTCGAGCTTCCGAAACGTCAAAGGATAACGAAG
ANG1079 3-1kb-YﬂE CAACTCGTTTGGAGAGTGGATGCTC
ANG1082 5-1kb-YqgS GCAAGCTGGATGAGCTGCAAAAACC
ANG1083 3-ApaI-YqgS CCGGGGCCCCATTCAACCTCCTATGCAGCACGCTC
ANG1084 5-XhoI-YqgS CCGCTCGAGCGGAAAGAAAAACAAATGCTTGATC
ANG1085 3-1kb-YqgS CGGCTCCGTAAGCGGAGAGATTCCC
ANG1088 5-1kb-YvgJ TAGAGCCAAGCCCTATCCGCATGTGG
ANG1089 3-ApaI-YvgJ CCGGGGCCCCAATATGACTCCTCACGTTTTCTTG
ANG1090 5-XhoI-YvgJ CCGCTCGAGGTGACCTGCTCAGGTTTTCCGAATG
ANG1091 3-1kb-YvgJ CTTACCGTGTCGGAAGGCAGATGCG
Relevant restriction sites in primer sequences are underlined.
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Protein expression, Ni-affinity and size exclusion protein
puriﬁcation were undertaken as described previously with
the modiﬁcation that protein expression was induced at an
OD600 of 0.4 by the addition of 0.5 mM isopropyl b-D-1-
thiogalactopyranoside (IPTG) (Lu et al., 2009). Fractions
containing the puriﬁed protein were pooled and concentrated
using Amicon centricons with a 10 kDa cut-off. The protein
concentration was measured using the BCA kit from Pierce
and the purity of the protein was estimated by separating
10 mg puriﬁed protein on 10% SDS-PAGE gels and Coo-
massie staining.
In vitro enzyme assay for LtaS-type enzymes
The enzymatic activity of puriﬁed proteins was measured by
following the hydrolysis of NBD-labelled PG (NBD-PG) using
a method described previously (Karatsa-Dodgson et al.,
2010). Brieﬂy, 1.8 ml of 10 mM sodium succinate buffer, pH
6.0, ionic strength (m) = 50 mM (adjusted with NaCl) was
added to 25 mg of TLC-puriﬁed NBD-PG lipid (Avanti; order
number 810163). Lipids were brought into suspension by
sonication for 45 s at 11 amplitude microns using a Soniprep
Sanyo sonicator. Next, MnCl2 or other divalent cations were
added from a 1 M stock solution to give a ﬁnal concentration
of 10 mM, the samples were vortexed and 303 ml( ~4.166 ng
lipid) aliquots transferred into test tubes. Reactions were
initiated by the addition of 1.52 mM puriﬁed protein and assay
mixtures were then incubated for 3 h in a 37°C water bath.
Next, reactions were stopped and lipids extracted by the
addition of CHCl3/MeOH to give a ﬁnal ratio of assay
volume : CHCl3 : MeOH of 0.9:1:1. Tubes were vortexed vig-
orously, centrifuged for 5 min at 17 000 g and fractions of the
bottom chloroform phase transferred to a new tube and dried
under a stream of nitrogen. Dried lipids were then suspended
in 10 ml chloroform, spotted onto pre-run Å60 silica gel plates
(Macherey-Nagel) and separated using a chloroform: metha-
nol: H2O (65:25:4) solvent system. Plates were dried and
subsequently scanned using a Fujiﬁlm FLA-5000 imager
equipped with a 473 nm excitation laser and a FITC emission
ﬁlter. Where indicated, ﬂuorescent signals of lipid reaction
products were quantiﬁed using the AIDA software (Raytest
Isotopenmessgeräte GmbH). The phospholipase PC-PLC
(PLC) from B. cereus (Sigma EC 3.1.4.3) was used as a
positive control enzyme and assays were set up as described
previously (Karatsa-Dodgson et al., 2010). To gain insight
into enzyme kinetics, a time-course experiment was per-
formed by removing and analysing samples at the indicated
time points. Reaction products were quantiﬁed using a ﬂuo-
rescence plate reader and the AIDA software and per cent
hydrolysis of input lipid calculated based on the signal
obtained for the PLC control reaction, which proceeds to near
completion. Reactions were set up with triplicate samples
and average values and standard deviations were plotted.
Experiments were performed three times and a representa-
tive result is shown. Maximal enzyme reaction rates were
determined from the slope of the linear ﬁt through the ﬁrst
three data points and average values with standard devia-
tions from the three independent experiments calculated. To
determine the enzyme speciﬁcity, the ﬂuorescently labelled
lipids 16:0-6:0 NBD-PC (Avanti 810130), 16:0-6:0 NBD-PE
(Avanti 810153) and 16:0-6:0 NBD-PS (Avanti 810192) were
puriﬁed on TLC plates and enzyme reactions set up as
described above. At least three independent experiments
were performed for all presented data and a representative
graph is shown.
S. aureus growth curves, LTA and protein detection by
Western blot
For growth curves, ltaS inducible S. aureus strains ANG1130
(pCN34), ANG1571 (pCN34itet-ltaS), ANG1573 (pCN34itet-
yfnI),ANG1662 (pCN34itet-yﬂE),ANG1658 (pCN34itet-yvgJ)
and ANG1654 (pCN34itet-yqgS) were grown overnight at
37°C in 4 ml TSB medium containing 1 mM IPTG and appro-
priate antibiotics. The following day, bacteria from 1 ml
culture were washed three times with 1 ml TSB by centrifu-
gation and resuspension. Next, 5 ml TSB containing
300 ng ml
-1 anhydrotetracycline (Atet) and appropriate anti-
biotics were inoculated with 50 ml washed bacterial suspen-
sions (1:100 dilution) and cultures incubated at 37°C with
shaking. At time 0 and 2 h intervals, culture aliquots were
removed and OD600 values determined.At 4 h all cultures and
at 8 h indicated cultures were diluted 1:100 into 5 ml fresh
TSB containing 300 ng ml
-1Atet and appropriate antibiotics to
maintain bacteria in the logarithmic growth phase. In addition,
4 h after the initial dilution, 1 ml aliquots were withdrawn for
sample preparation for Western blot analysis of cell-
associated LTA. Samples for Western blot analysis were pre-
pared as described previously (Gründling and Schneewind,
2007a). Samples were normalized for OD600 readings of the
bacterial cultures; that is, samples from a culture with an
OD600 of 1 were suspended in 15 ml sample buffer. Samples
were boiled for 20 min, centrifuged at 17 000 g for 5 min and
10 ml aliquots separated on a 15% SDS-PAGE gel. For
Western blot analysis, the polyglycerolphospate-speciﬁc LTA
antibody (Clone 55 from Hycult biotechnology) and HRP-
conjugated anti-mouse IgG (Cell Signaling Technologies,
USA) were used at 1:5000 and 1:10 000 dilutions
respectively. Antibody incubations were performed in Tris-
buffered saline pH 7.6, 0.1% Tween 20 (TBST) buffer con-
taining 5% milk and 10 mgm l
-1 human IgG and blots were
developed by enhanced chemiluminesce. For LTA detection
in B. subtilis, wild-type and mutant strains were grown for
20–22 h at 30°C in 5 ml PAB medium with shaking. Samples
for LTA analysis were prepared from whole cells as follows:
Bacteria from 3–4 ml culture were collected by centrifugation
for 30 min at 17 000 g. Bacterial pellets were suspended in
2¥ protein sample buffer normalized for OD600 readings; that
is 100 ml2 ¥ sample buffer was used per ml culture of
OD600 = 3. Samples were boiled for 45 min, centrifuged for
5 min and 10 ml analysed on a 15% SDS-PAGE gel. The
humanized monoclonal LTA antibody (Biosynexus Incorpo-
rated; Gaithersburg, MD, USA) and the HRP-conjugated
polyclonal rabbit anti-human IgA, IgG, IgM, Kappa, Lambda
antibody (DakoCytomation) were used at 1:10 000 dilutions
for LTA detection. Antibody incubations were performed in
TBST buffer containing 3% BSA. All experiments were per-
formed at least three times and a representative graph is
shown.
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For S. aureus lipid extraction and glycolipid analysis, strains
ANG1130 (pCN34), ANG1571 (pCN34itet-ltaS), ANG1573
(pCN34itet-yfnI), ANG1662 (pCN34itet-yﬂE), ANG1658
(pCN34itet-yvgJ) and ANG1654 (pCN34itet-yqgS) were
grown overnight at 37°C in 10 ml TSB supplemented with
1 mM IPTG and appropriate antibiotics. The next day, cells
were collected by centrifugation for 10 min at 1300 g and
bacterial pellets washed three times with 10 ml TSB.After the
ﬁnal centrifugation step, washed cultures were suspended in
10 ml TSB and diluted 1:100 into 200–800 ml fresh TSB
medium supplemented with 300 ng ml
-1 Atet and appropriate
antibiotics. Cultures were incubated at 37°C with shaking for
5 h. Next, bacteria were collected by centrifugation for 10 min
at 8000 g, washed once with 5 ml of ice-cold 0.1 M sodium
citrate buffer pH 4.7 and suspended in 3 ml of the same
buffer. Cultures were subsequently dispensed into three 2 ml
Fast Prep tubes containing 0.5 ml of 0.1 mm glass beads.
Bacteria were lysed and lipids extracted using a modiﬁed
Bligh-Dyer method as described previously (Kates, 1972;
Gründling and Schneewind, 2007a). Lipids were dried under
a stream of nitrogen and suspended in chloroform to a ﬁnal
concentration of 50 mg ml
-1. Ten microlitres (500 mg lipids)
was spotted onto pre-run Å60 silica gel plates (Macherey-
Nagel) and lipids separated using a chloroform :
methanol : H2O (65:25:4) solvent system. Glycolipids were
visualized by spraying plates with 0.5–1.5% a-naphthol in
50% methanol and then with 95% H2SO4 (Gründling and
Schneewind, 2007a; Kates, 1972). Experiments were per-
formed three times and a representative result is shown.
Lipid analysis by MALDI mass spectrometry
The MALDI mass spectrometry analysis was essentially per-
formed as described previously (Webb et al., 2009). Brieﬂy,
total membrane lipids were isolated from S. aureus strains
ANG1662 (expressing LtaSBS) or ANG1658 (expressing
YvgJ) and 5 ¥ 0.5 mg lipids (2.5 mg total) were spotted and
separated on a TLC plate using the same solvent system as
described above. Areas containing glycolipids were deter-
mined by developing one lane run in parallel with a-naphthol/
H2SO4. Appropriate silica gel areas were scraped off and
lipids extracted as described previously (Gründling and
Schneewind, 2007a). Dried lipids were suspended in 10 mlo f
0.5 M 2,5-dihydroxybenzoic acid (DHB) MALDI matrix dis-
solved in 1:1 methanol: chloroform and 1 ml was spotted
directly onto MALDI plates or diluted 1:10 using 0.5 M DHB
matrix and 1 ml spotted. Spotted MALDI plates were run on a
MALDI micro MX machine (Waters, UK) and spectra
recorded in the reﬂector positive ion mode. As additional
calibration standard, 25–50 pmol of bradykinin peptide stan-
dard (Sigma) with an absolute mass of 7 573 997 (M + H
+)
was spotted in a-cyano-4-hydroxycinnamic acid (CHCA)
matrix, which was suspended at 10 mg ml
-1 in 70% acetoni-
trile 0.1% TFA. Representative spectra from three indepen-
dent experiments are shown.
Microscopy
Wild-type and mutant B. subtilis strains (ANG1691 –
ANG1699 and ANG 1701) were grown overnight at 30°C in
5 ml PAB medium. Overnight cultures were processed for
microscopy analysis as described below or were back-diluted
1/50 into fresh PAB medium and grown for 3 h at 37°C with
shaking. Subsequently, an equivalent of a 1 ml culture aliquot
with an OD600 = 0.5 was removed and bacteria washed three
times by centrifugation and suspension in 1 ml PBS pH 7.4
buffer. A small aliquot of washed culture was mounted on
poly-lysine coated microscope slides and examined under a
Zeiss Axiovert 200 wide ﬁeld microscope using a 100¥ objec-
tive and images were taken and analysed using the Improvi-
sion Volocity software. Two independent experiments were
performed and representative images are shown for each
strain.
LTA puriﬁcation
Lipoteichoic acid was puriﬁed from S. aureus strains using a
previously described 1-butanol extraction method (Morath
et al., 2001; Gründling and Schneewind, 2007a). Brieﬂy,
strains ANG514 (expressing LtaS) and ANG515 (expressing
YfnI) were grown overnight at 37°C with shaking in 150 ml
TSB supplemented with 1 mM IPTG and appropriate
antibiotics. The following day, cultures were centrifuged for
10 min at 1300 g and washed three times with 150 ml TSB.
Washed cultures were diluted 1:100 into 6 l (strain ANG514)
or 12 l (strainANG515) fresh TSB containing 300 ng ml
-1Atet
and appropriate antibiotics and incubated at 37°C with
shaking for 4–5 h. LTA extraction and puriﬁcation by hydro-
phobic interaction chromatography was performed as
described previously using a 24 ¥ 1.6 cm octylsepharose
column (Gründling and Schneewind, 2007a). LTA-containing
fractions were identiﬁed by Western blot, pooled and dialysed
in the cold 7–11 times against 4 l ddH2O and subsequently
lyophilized.
LTA structure analysis by NMR and biochemical assays
For NMR analysis, 1 mg puriﬁed LTA was suspended in
500 mlD 2O of 99.96% purity and lyophilized. This procedure
was repeated once and the lyophilized LTA sample was then
suspended in 500 mlD 2O of 99.99% purity and 1d
1H NMR
spectra recorded at 600 MHz (
1H) and 300 K on a Bruker
AvanceIII spectrometer equipped with a TCI cryoprobe. To
ensure accurate integrals of species with potentially differing
1HT 1 values, spectra were recorded with a total recycle time
of 6 s and a
1H ﬂip angle of c. 60°. The length of the glycer-
olphosphate chain as well as the percentage of D-alanine
substitution was calculated from the
1H NMR integrals of the
appropriate LTA-speciﬁc peaks. The LTA length calculation
was based on a C15:C18 fatty acid composition (59 non-
exchangeable protons from CH2/CH3 groups), which is the
most abundant lipid anchor present in S. aureus LTA(Fischer,
1994). NMR analysis was performed on LTAsamples isolated
from three independent cultures.
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